| Symbol | RFL |
|---|---|
| Name | RAFAEL HOLDINGS, INC. |
| Sector | FINANCE |
| Region | North America |
| Industry | Real Estate |
| Address | 520 BROAD STREET, NEWARK, New Jersey, 07102, United States |
| Telephone | +1 212 - 658-1450 |
| Fax | — |
| — | |
| Website | https://www.rafaelholdings.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001713863 |
| Description | Rafael Holdings includes commercial real estate assets and interests in two clinical-stage pharmaceutical companies backed by a strong and liquid balance sheet. Rafaels real estate holdings are comprised by a 20-story commercial office building and associated parking garage in Newark, New Jersey, an office/data center building in Piscataway, New Jersey and an office condominium in Israel. Rafaels pharmaceutical holdings include interests in two clinical-stage oncology companies - Rafael Pharmaceuticals and LipoMedix. Rafael Pharmaceuticals is developing therapies that exploit the metabolic differences between normal cells and cancer cells in both solid and liquid cancers. LipoMedix is developing liposomal prodrugs designed to enhance the efficacy of certain chemotherapeutic therapies. Additional info from NASDAQ: |
Polinsky David 🔴 sold 2.4K shares of Rafael Holdings, Inc. (RFL) at $2.63 Transaction Date: Jun 21, 2026 | Filing ID: 279350
Read moreJONAS HOWARD S 🟡 adjusted position in 134.1K shares of Rafael Holdings, Inc. (RFL) at $2.33 Transaction Date: Jun 13, 2026 | Filing ID: 272548
Read more(30% Negative) RAFAEL HOLDINGS, INC. (RFL) Reports Q2 2026 Financial Results
Read more(90% Positive) RAFAEL HOLDINGS, INC. (RFL) Announces Clinical Development Update
Read moreRafael Holdings Announces Patent Licensing Agreement with MIT for “Small Molecules to Improve Myelination in ApoE4 positive Alzheimer’s Disease”
Read morePolinsky David 🔴 sold 2.3K shares of Rafael Holdings, Inc. (RFL) at $1.27 Transaction Date: Mar 21, 2026 | Filing ID: 121225
Read more